Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Digestive Neuroendocrine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Not applicableLooking for participantsNCT04520932
What this trial is testing

Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor of Pancreas (Disorder)Neuroendocrine Tumor Grade 1
Institut Paoli-Calmettes 82
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Not applicableLooking for participantsNCT07042243
What this trial is testing

The Florida ASCENT Study

Who this might be right for
CancerFood DeprivationFood Habits+11 more
University of Florida 100
Testing effectiveness (Phase 2)Study completedNCT05302921
What this trial is testing

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+7 more
Children's National Research Institute 5
Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Not applicableStudy completedNCT05476978
What this trial is testing

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatitis, ChronicPancreatic Neuroendocrine Tumor+1 more
Huazhong University of Science and Technology 130
Not applicableUnknownNCT00757614
What this trial is testing

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more
Cancer Research UK 14,000
Early research (Phase 1)Active Not RecruitingNCT03872947
What this trial is testing

TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorColorectal CancerCholangiocarcinoma+9 more
Toray Industries, Inc 138
Very early researchActive Not RecruitingNCT04993261
What this trial is testing

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Who this might be right for
Carcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT01739634
What this trial is testing

The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer

Who this might be right for
DiarrheaMedullary Thyroid Cancer
Salient Pharmaceuticals Incorporated 10
Testing effectiveness (Phase 2)Looking for participantsNCT06281678
What this trial is testing

IBI363 in Subjects with Advanced Solid Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer+1 more
Innovent Biologics (Suzhou) Co. Ltd. 178
Testing effectiveness (Phase 2)WithdrawnNCT04915144
What this trial is testing

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorPulmonary Carcinoid Tumor+4 more
British Columbia Cancer Agency
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07712094
What this trial is testing

AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Cancer
Tianjin Medical University Cancer Institute and Hospital 56
Not applicableLooking for participantsNCT07479446
What this trial is testing

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Who this might be right for
PONVCerebellopontine Angle TumorMicrovascular Decompression Surgery+1 more
Xuanwu Hospital, Beijing 174
Early research (Phase 1)Study completedNCT02857270
What this trial is testing

LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic MelanomaMetastatic Non-small Cell Lung Cancer+1 more
Eli Lilly and Company 210
Next Page